Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01839760 · ClinicalTrials.gov registry record
Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients
A clinical trial, sponsored by Crucell Holland.
- Completed
- Registry status
- 150
- Enrollment target
NCT01839760: Completed study, sponsored by Crucell Holland.
NCT01839760 is a clinical trial that has completed, run by Crucell Holland. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01839760 has completed, sponsored by Crucell Holland.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifestations and prognosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2012-12 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01839760
The ClinicalTrials.gov registry entry for NCT01839760 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Crucell Holland, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01839760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01839760 about?
NCT01839760 is a clinical study titled "Evaluation of Viral Shedding Patterns and Clinical Outcomes of Influenza Patients". The objective of the study is virological assessment (e.g., proportion of prolonged viral shedding, median days to viral clearance, and viral load) in laboratory-confirmed adult influenza patients admitted to the general ward and/or to the ICU and to assess the correlation with the clinical manifest...
What is the current status of trial NCT01839760?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2012-12. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT01839760?
This trial is sponsored by Crucell Holland, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.